Reem Karmali
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma (NCT06723457) | Reem Karmali | 2025-07-25 |
Track Reem Karmali automatically
Every clearance here is in the API, with alerts when new ones post.